Asset Details
Do you wish to reserve the book?
Clinical and Laboratory Features of the Catastrophic Antiphospholipid Syndrome
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Clinical and Laboratory Features of the Catastrophic Antiphospholipid Syndrome
Do you wish to request the book?
Clinical and Laboratory Features of the Catastrophic Antiphospholipid Syndrome
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Clinical and Laboratory Features of the Catastrophic Antiphospholipid Syndrome
2009
Overview
Catastrophic antiphospholipid syndrome (CAPS,
Asherson’s syndrome
) is an unusual form of antiphospholipid syndrome (APS) characterized by multi-organ failure and high mortality. Fortunately, CAPS accounts for less than 1% of APS cases. Due to the rarity of the condition, an international registry of CAPS patients was created in 2000 supported by the European Forum on Antiphospholipid Antibodies held in Taormina, Italy at the Tenth International Congress on Antiphospholipid Antibodies. Clinical and laboratory features are the most important in the criteria for the diagnosis of this syndrome and can affect many organ systems. The majority of patients presented with multiple organ involvement at the time of CAPS. The combination of pulmonary, cardiac, and renal involvement was most commonly seen. The organ systems most commonly involved at the onset include the cardiopulmonary system, primarily characterized by dyspnea and respiratory failure, the central nervous system, and the renal system. Laboratory criteria for the classification of CAPS include the presence of antiphospholipid antibodies—LA and/or aCL and/or β
2
-GPI antibodies.
Publisher
Humana Press Inc,Springer Nature B.V
Subject
/ Antibodies, Anticardiolipin - immunology
/ Antiphospholipid Syndrome - blood
/ Antiphospholipid Syndrome - diagnosis
/ Antiphospholipid Syndrome - genetics
/ Antiphospholipid Syndrome - immunology
/ Antiphospholipid Syndrome - physiopathology
/ Dyspnea
/ Genetic Predisposition to Disease
/ Humans
/ Lupus Coagulation Inhibitor - immunology
/ Medicine
/ Molecular Mimicry - immunology
/ Neovascularization, Pathologic - immunology
